Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 7Other neoplasm 1

Conditions

Precancerous Conditions 3Uterine Cervical Dysplasia 2Uterine Cervical Neoplasms 1Papillomavirus Infections 1

Interventions

Colposcopy 5Biopsy 3Polymerase Chain Reaction 2Imiquimod 2human papillomavirus vaccine, TA 1human papillomavirus vaccine, L1 type 16, 18 1Zoledronic Acid 1Watchful Waiting 1Vaginal Smears 1Tretinoin 1Transurethral Resection of Prostate 1Spectrum Analysis 1Spectrometry, Fluorescence 1Sodium Chloride 1Robotic Surgical Procedures 1Radiotherapy 1Pregnancy Tests 1Papanicolaou Test 1Mindfulness-Based Stress Reduction 1Microarray Analysis 1Immunohistochemistry 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Histological Techniques 1Folic Acid 1Fluorophotometry 1Flow Cytometry 1Fenretinide 1Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Vaginal Smears × Other neoplasm × Clear all
NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡